scispace - formally typeset
Open AccessJournal ArticleDOI

Lipid pathway deregulation in advanced prostate cancer.

TLDR
There is growing evidence implicating the role of obesity and peri‐prostatic adipose tissue (PPAT) in PC aggressiveness and related mortality, suggesting the importance of lipid pathways in both localised and disseminated disease.
About
This article is published in Pharmacological Research.The article was published on 2018-05-01 and is currently open access. It has received 68 citations till now. The article focuses on the topics: Lipid metabolism & Prostate cancer.

read more

Citations
More filters
Journal ArticleDOI

Sterculic Acid: The Mechanisms of Action beyond Stearoyl-CoA Desaturase Inhibition and Therapeutic Opportunities in Human Diseases.

TL;DR: The mechanisms by which Sterculic acid exerts its actions are summarized and the emerging areas where this natural compound may be of help for the development of new therapies for human diseases are highlighted.
Journal ArticleDOI

PPAR-gamma induced AKT3 expression increases levels of mitochondrial biogenesis driving prostate cancer.

TL;DR: In this article, a functional effect of PPARG on AKT serine/threonine kinase 3 (AKT3) was identified, which resulted in a more aggressive disease phenotype.
Journal ArticleDOI

Astragalus Polysaccharides Inhibits Tumorigenesis and Lipid Metabolism Through miR-138-5p/SIRT1/SREBP1 Pathway in Prostate Cancer.

TL;DR: It is suggested that APS inhibits tumorigenesis and lipid metabolism through miR-138-5p/SIRT1/SREBP1 pathways in PCa in a dose-dependent and time-dependent manner in vitro and in vivo.
Journal ArticleDOI

Cationic Polymer Nanoparticles-Mediated Delivery of miR-124 Impairs Tumorigenicity of Prostate Cancer Cells.

TL;DR: It is demonstrated that the use of PHB-PEI NPs represents a suitable and convenient strategy to develop novel nanomaterials with excellent biocompatibility and high transfection efficiency for cancer therapy.
Journal ArticleDOI

LKB1 deficiency-induced metabolic reprogramming in tumorigenesis and non-neoplastic diseases.

TL;DR: It is concluded that in-depth knowledge of metabolic pathways regulated by LKB1 is conducive to identifying therapeutic targets and developing drug combinations to treat cancers and metabolic diseases and achieve immunoregulation.
References
More filters
Journal ArticleDOI

Cancer statistics, 2015.

TL;DR: The overall cancer death rate decreased from 215.1 (per 100,000 population) in 1991 to 168.7 in 2011, a total relative decline of 22%.
Journal ArticleDOI

Obesity is associated with macrophage accumulation in adipose tissue

TL;DR: Transcript expression in perigonadal adipose tissue from groups of mice in which adiposity varied due to sex, diet, and the obesity-related mutations agouti (Ay) and obese (Lepob) found that the expression of 1,304 transcripts correlated significantly with body mass.
Journal ArticleDOI

Lipid rafts and signal transduction

TL;DR: It is now becoming clear that lipid micro-environments on the cell surface — known as lipid rafts — also take part in this process of signalling transduction, where protein–protein interactions result in the activation of signalling cascades.
Journal ArticleDOI

Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate

TL;DR: Gutman et al. as mentioned in this paper showed that the acid phosphatase of serum is reduced in metastatic carcinoma of the prostate by decreasing the activity of androgens through castration or estrogenic injections and that this enzyme is increased by injecting androgens.
Journal Article

Studies on Prostatic Cancer. I. The Effect of Castration, of Estrogen and of Androgen Injection on Serum Phosphatases in Metastatic Carcinoma of the Prostate

TL;DR: It is demonstrated that a marked rise in acid phosphatase in serum is associated with the appearance or spread of roentgenologically demonstrable skeletal metastases and implies dissemination of the primary tumor and thus is of unfavorable prognostic significance.
Related Papers (5)
Frequently Asked Questions (18)
Q1. What is the role of adipokine gradient in prostate cancer?

Matrix metallo-proteases, MMP2 and MMP9 promote metastasis whilst CCL7 and CCR3 have been linked to generation of an adipokine gradient giving directionality to tumour cell migration. 

For instance, de novo synthesis of mono-unsaturated and saturated lipids plays key roles in signal transduction, intracellular trafficking, cell polarisation and migration (8-10). 

Thiazolidinedione activation of peroxisome proliferator-activated receptor gamma can enhance mitochondrial potential and promote cell survival. 

Silibinin activates AMPK, which in turnphosphorylates SREBP preventing SREBP cleavage and its subsequent nucleartranslocation and resultant activation of SREBP target genes (83, 84). 

PPAT is able to promotetumour growth and migration through increased matrix metalloproteinaseactivity of MMP2 and MMP9, which are released into the tumourmicroenvironment (72). 

Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts. 

IL-6 is produced by theadipose tissue surrounding the prostate, such as the PPAT, and is involved inregulation of proliferative responses and cell death (78). 

Androgens regulate the mRNA and protein expression of one of the key regulators of lipid metabolism, the sterol regulatory element-binding protein (SREBP). 

Several therapeutic agents, Warfarin, Fatostatin, Orlistat (green rectangles red lines) are known to block key processes in lipid metabolism and have a negative effect on PC progression. 

The premise behind their use being that upon treatment with TZD’sPPARG is activated and in a dose dependant manner relieving the effects ofhyperglycaemia. 

High-level expression of fatty acid synthase in human prostate cancer tissues is linked to activation and nuclear localization of Akt/PKB. 

Another molecule, Fatostatin, a synthetic diarylthiazole derivative, is known toblock adipogeneis through inhibition of SREBP (85). 

Key Regulators of Lipid Metabolism in PC Sterol Regulatory Element-Binding Protein 1 (SREBP1) SREBP1 is a master regulator in FA metabolism. 

A UKregistry based study found that post-diagnosis statin use was associated withreduced PC mortality, particularly among patients who had used it prior to thediagnosis of PC (94). 

Thiazolidinediones (TZDs) are synthetic PPARG agonistsand have been successfully used in the treatment of type II diabetes, for reviewsee (87). 

Inhibition of FASN has beenfound to cause selective apoptosis of cancer cell in multiple cancer types (100),however the mechanism behind this remains unclear. 

Fritz V, Benfodda Z, Rodier G, Henriquet C, Iborra F, Avances C, Allory Y, de la Taille A, Culine S, Blancou H, Cristol JP, Michel F, Sardet C, Fajas L. Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice. 

their work as well as that of others suggests that PPARG does not affect the initiation of the primary tumour (34), at least in the mouse models examined, but has a role more specific to the development of aggressive metastatic disease (32).